GRI Bio ( ($GRI) ) has shared an update. On December 11, 2025, GRI Bio, Inc. initiated a public offering involving shares of common stock, ...

The aggregate gross proceeds to the Company from the offering were approximately $8.0 million before deducting the placement agent's fees and other offering expenses payable by the Company. The ...

GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural ...

GRI Bio, Inc. (NASDAQ: GRI) ("GRI Bio" or the "Company"), a biotechnology company advancing an innovative pipeline of Natural Killer T ("NKT") cell modulators ...

Study met its primary endpoint demonstrating that GRI-0621 was well tolerated over 12 weeks of treatment, with no drug-related severe or serious ...

GRI has published an updated version of the CSRD Questions and Answers. The publication discusses the answers to the main business questions on the CSRD topic. This is stated in the company's message.

GRI-0621, an experimental oral therapy from GRI Bio, boosts lung function in adults with IPF, according to top-line clinical ...

With all of the major carriers introducing general rate increases for 2026, the cost of shipping hard parts will increase ...

South Africa’s Competition Commission has referred a complaint against eight major container shipping companies to the Competition Tribunal, alleging that the carriers coordinated General Rate ...

Two F/A-18E/F Super Hornet jets cutting tight circles over the Gulf of Venezuela would be provocative in any political ...